TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“Conavi” or the “Company”) (TSXV: CNVI) is pleased to announce that, pursuant to its press releases dated September 30, 2024 and October 11, 2024, the Company’s common shares (“Common Shares”) have been voluntarily delisted from the Toronto Stock Exchange, effective as of close of markets on October 15, 2024, and will commence trading at the market open today on the TSX Venture Exchange (the “TSXV”) under the new symbol “CNVI”. The Company has been classified by the TSXV as a Tier 2 Technology issuer.
On October 11, 2024, the Company completed a reverse takeover with Conavi Medical Inc. in an all-stock transaction (the “Transaction”). Further details regarding the Transaction are set out in the Company’s press release dated October 11, 2024.
“The completion of the Transaction and our listing on the TSXV comes…
